Articles for Business, Filtered by: Research
June 9, 2016 | Damir Ljuboja, BS, BA; Brian W. Powers, AB; Benjamin Robbins, MD, MBA; Robert Huckman, PhD; Krishna Yeshwant, MD, MBA; and Sachin H. Jain, MD, MBA
Large-scale analysis of Harvard Business School’s physician graduates yields new insights into physician-MBA career choices and the utility of these programs.
April 20, 2015 | Mary K. Caffrey, Managing Editor, Evidence-Based Oncology and Evidence-Based Diabetes Management
Panelists agreed that the trend of specialization of traditional drug classes has implications not only for costs, but also for the role of community pharmacy if more drugs fall into the specialty pharmacy realm.
December 11, 2013 | James A. Jorgenson, RPh, MS, FASHP
A major opportunity to improve patient outcomes and organizational finances exists in the pharmacy service line.
April 8, 2013 | James A. Jorgenson, RPh, MS, FASHP
With the approval of biosimilars in the United States, a key safety issue is the naming configuration. This article discusses the issues and options around biosimilar naming.